Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group.
Raney
Beverly
B
Division of Pediatrics and The Children's Cancer Hospital, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. rbraney@austin.rr.com
Stoner
Julie
J
Anderson
James
J
Andrassy
Richard
R
Arndt
Carola
C
Brown
Ken
K
Crist
William
W
Maurer
Harold
H
Qualman
Stephen
S
Wharam
Moody
M
Wiener
Eugene
E
Meyer
William
W
Hayes-Jordan
Andrea
A
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D003952:Diagnostic Imaging / Q000379:methods*; D018572:Disease-Free Survival; D019583:Dose Fractionation, Radiation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D018365:Neoplasm, Residual; D012189:Retrospective Studies; D012208:Rhabdomyosarcoma / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D024162:Second-Look Surgery / Q000379:methods*; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000970:Antineoplastic Agents